Marshall S. Stanton

Marshall S. Stanton

Senior Vice President, Clinical Research and Chief Medical OfficeratArtivion· In proxies 2022–2025

Pay in FY2025+28% from the year before

Marshall S. Stanton was paid $1.7M in FY2025 (Dec), up 28%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Artivion proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. ArtivionPublic company · 4 yr
    • Senior Vice President, Clinical Research and Chief Medical Officer2022 – Present · 4 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?